ARTICLE | Company News

Crescendo Bioscience sales and marketing update

November 15, 2010 8:00 AM UTC

Crescendo launched multi-biomarker blood test Vectra DA in 47 states as a baseline assessment to quantify rheumatoid arthritis activity in adults. The test combines information from 12 serum biomarkers that have been shown to be associated with RA disease activity into a single quantitative score. The company said the test is not intended or validated to diagnose RA. ...